OUTSOURCE
Immunohistochemistry, Progesterone Receptor ; PR (J010)
Also Known As:
IHC PR
PR
IHC Progesterone Receptor
About This Test
Progesterone receptor (PR) is a surrogate marker of Estrogen receptor (ER) activity in the management of women with breast cancer. ER & PR status provides an indication of prognosis and potential benefit from hormonal therapy. Generally ER & PR positive tumors are more likely to respond to endocrine therapy and have a better prognosis, stage for stage as compared to receptor negative tumors. This test is recommended in patients with newly diagnosed breast cancer and metastatic & recurrent breast cancer.
Test Parameters (1)
- IMMUNOHISTOCHEMISTRY, PROGESTERONE RECEPTOR ; PR
Home Collection
✓ Available
Reports Available In
7 Days
Frequently Asked Questions
Outsourced test are being done from Dr. Lal Path Lab. Charges and reporting time is same as of Dr. Lal Path Labs.
Provide a copy of the Histopathology report.
Progesterone receptor (PR) is a protein found on some breast cancer cells that allows them to respond to the hormone progesterone. PR testing is usually done alongside Estrogen Receptor (ER) testing to evaluate hormone receptor status of the tumor.
TAT Policy
The Turnaround Time (TAT) depends on the following factors:
- Registration date and time
- Type of scan or test
- Scan time or sample collection time
In uncommon circumstances, TAT may be delayed due to test complexity or reasons beyond our control. You will be informed of the estimated TAT at the time of registration.
